[HTML][HTML] Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind …
…, F Cappuccini, M Carr, MW Carroll, P Cashen, A Cavey… - The Lancet, 2020 - thelancet.com
Background Older adults (aged ≥70 years) are at increased risk of severe disease and
death if they develop COVID-19 and are therefore a priority for immunisation should an …
death if they develop COVID-19 and are therefore a priority for immunisation should an …
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study
…, PR Armenteros, M Ashraghi, A Cavey… - The Lancet …, 2023 - thelancet.com
Background Generalised myasthenia gravis is a chronic, unpredictable, and debilitating rare
disease, often accompanied by high treatment burden and with an unmet need for more …
disease, often accompanied by high treatment burden and with an unmet need for more …
Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride
…, L Matthews, MI Leite, R Gelineau-Morel, A Cavey… - Brain, 2013 - academic.oup.com
Neurodegeneration is the main cause for permanent disability in multiple sclerosis. The effect
of current immunomodulatory treatments on neurodegeneration is insufficient. Therefore, …
of current immunomodulatory treatments on neurodegeneration is insufficient. Therefore, …
A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis
Objective: We tested whether it is possible to differentiate relapsing-remitting (RR) from
secondary progressive (SP) disease stages in patients with multiple sclerosis (MS) using a …
secondary progressive (SP) disease stages in patients with multiple sclerosis (MS) using a …
[HTML][HTML] Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease
The overlapping clinical features of relapsing remitting multiple sclerosis (RRMS), aquaporin-4
(AQP4)-antibody (Ab) neuromyelitis optica spectrum disorder (NMOSD), and myelin …
(AQP4)-antibody (Ab) neuromyelitis optica spectrum disorder (NMOSD), and myelin …
Contrasting the brain imaging features of MOG-antibody disease, with AQP4-antibody NMOSD and multiple sclerosis
…, A Roca-Fernandez, A Cavey… - Multiple Sclerosis …, 2022 - journals.sagepub.com
Background: Identifying magnetic resonance imaging (MRI) markers in myelin-oligodendrocytes-glycoprotein
antibody-associated disease (MOGAD), neuromyelitis optica spectrum …
antibody-associated disease (MOGAD), neuromyelitis optica spectrum …
Autoantibodies to glutamic acid decarboxylase in patients with epilepsy are associated with low cortical GABA levels
CJ Stagg, B Lang, JG Best, K McKnight, A Cavey… - …, 2010 - Wiley Online Library
Antibodies to glutamic acid decarboxylase (GAD), the major pathway for the synthesis of γ‐aminobutyric
acid (GABA) in humans, are found at elevated levels in a subgroup of patients …
acid (GABA) in humans, are found at elevated levels in a subgroup of patients …
A randomised double-blind placebo-controlled feasibility trial of flavonoid-rich cocoa for fatigue in people with relapsing and remitting multiple sclerosis
…, L Durkin, M Kirsten, M Clegg, A Cavey… - Journal of Neurology …, 2019 - jnnp.bmj.com
The impact of flavonoids on fatigue has not been investigated in relapsing and remitting
multiple sclerosis (RRMS). Objective To determine the feasibility and estimate the potential …
multiple sclerosis (RRMS). Objective To determine the feasibility and estimate the potential …
Classifying the antibody-negative NMO syndromes: Clinical, imaging, and metabolomic modeling
…, M Jurynczyk, M Sealey, A Cavey… - Neurology …, 2019 - AAN Enterprises
Objective To determine whether unsupervised principal component analysis (PCA) of
comprehensive clinico-radiologic data can identify phenotypic subgroups within antibody-negative …
comprehensive clinico-radiologic data can identify phenotypic subgroups within antibody-negative …
Time-and region-specific season of birth effects in multiple sclerosis in the United Kingdom
PMR Cruz, L Matthews, M Boggild, A Cavey… - JAMA …, 2016 - jamanetwork.com
Importance The reports of seasonal variation in the births of people who later develop
multiple sclerosis (MS) have been challenged and attributed to the background pattern in the …
multiple sclerosis (MS) have been challenged and attributed to the background pattern in the …